Skip to main content
Clinical Trials/CTRI/2018/09/015808
CTRI/2018/09/015808
Completed
Phase 2

Pharmaceutico-Analytical study and clinical evaluation of Vanga preparations in Diabetes Mellitus (type-II)

ational Institute of Ayurveda Jaipur0 sites30 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Sponsor
ational Institute of Ayurveda Jaipur
Enrollment
30
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
March 31, 2019
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
ational Institute of Ayurveda Jaipur

Eligibility Criteria

Inclusion Criteria

  • Presence of sign and symptoms of Madhumeha described in Ayurveda classics
  • Confirmed cases of DM type II on the basis of laboratory investigations and observed sign and symptoms
  • Patients having F.B.S. level ranges between 100 â?? 160 mg/dl and P.P.B.S. between 160 â?? 200 mg/dl will be selected for the study

Exclusion Criteria

  • Patient with type I Diabetes mellitus.
  • Patients who are insulin dependent.
  • Patients of Gestational Diabetes.
  • Patient having Type\-II DM with any other serious systemic disease.
  • Nephropathy and other secondary complications
  • Diabetes Mellitus produced due to other illnesses like Acromegaly, Cushingâ??s syndrome, pancreatic disorders etc

Outcomes

Primary Outcomes

Not specified

Similar Trials